![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2020
Anzahl der Publikationen: 2
2020
Gross, Oliver; Toenshoff, Burkhard; Weber, Lutz T.; Pape, Lars; Latta, Kay; Fehrenbach, Henry; Lange-Sperandio, Baerbel; Zappel, Hildegard; Hoyer, Peter; Staude, Hagen; König, Sabine; John, Ulrike; Gellermann, Jutta; Hoppe, Bernd; Galiano, Matthias; Hoecker, Britta; Ehren, Rasmus; Lerch, Christian; Kashtan, Clifford E.; Harden, Markus; Boeckhaus, Jan und Friede, Tim
(2020):
A multicenter, randomized, placebo -controlled, double-blind phase 3 trial with open -arm comparison indicates safety and ef fi cacy of nephroprotective therapy with ramipril in children with Alport ? s syndrome see commentary.
In: Kidney International, Bd. 97, Nr. 6: S. 1275-1286
Boeckhaus, Jan; Hoefele, Julia; Riedhammer, Korbinian M.; Tonshoff, Burkhard; Ehren, Rasmus; Pape, Lars; Latta, Kay; Fehrenbach, Henry; Lange-Sperandio, Baerbel; Kettwig, Matthias; Hoyer, Peter; Staude, Hagen; Konrad, Martin; John, Ulrike; Gellermann, Jutta; Hoppe, Bernd; Galiano, Matthias; Gessner, Michaela; Pohl, Michael; Bergmann, Carsten; Friede, Tim und Gross, Oliver
(2020):
Precise variant interpretation, phenotype ascertainment, and genotype-phenotype correlation of children in the EARLY PRO-TECT Alport trial.
In: Clinical Genetics, Bd. 99, Nr. 1: S. 143-156